Human umbilical cord mesenchymal stem cells promoting knee joint chondrogenesis for the treatment of knee osteoarthritis: a systematic review.
Chondrocytes
Exosomes
Inflammation
Knee
Osteoarthritis
Regenerative medicine
Safety
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
29 Aug 2023
29 Aug 2023
Historique:
received:
19
04
2023
accepted:
23
08
2023
medline:
31
8
2023
pubmed:
30
8
2023
entrez:
29
8
2023
Statut:
epublish
Résumé
The onset of OA is affected by a variety of factors, which eventually lead to the loss of cartilage in the joints, the formation of osteophytes, the loss of normal knee mobility, and pain and discomfort, which seriously affects the quality of life. HUC-MSCs can promote cartilage production and have been widely used in research in the past decade. This article systematically summarizes that it is well used in basic research and clinical studies to promote inflammatory chondrogenesis in the treatment of OA. Provide a theoretical basis for clinical treatment. This study collected CNKI, Wanfang, PubMed, and articles related to the treatment of OA with HUC-MSCs since their publication, excluding non-basic and clinical studies such as reviews and meta-analysis. A total of 31 basic experimental studies and 12 clinical studies were included. Systematically analyze the effects of HUC-MSCs on inhibiting inflammatory factors, promoting chondrocyte production, and current clinical treatment. HUC-MSCs can reduce inflammatory factors such as MMP-13, ADAMTS-5, IL-1β, IL-1, IL-6, TNF-α, induced conversion from M1 to M2 in OA to protect cartilage damage and reduce OA inflammation. Synthesize ColII, SOX9, and aggrecan at the same time to promote cartilage synthesis. HUC-MSCs not only have typical stem cell biological characteristics, but also have rich sources and convenient material extraction. Compared with stem cells from other sources, HUC-MSCs have stronger proliferation, differentiation, and immune regulation abilities. Furthermore, there are no ethical issues associated with their use. Primarily attributed to pain, the majority of individuals experience recovery within 24 h following injection. HUC-MSCs possess the ability to alleviate pain, enhance knee joint function, and potentially postpone the need for surgical intervention in both non-surgical and other cases, making them highly deserving of clinical promotion and application.
Identifiants
pubmed: 37644595
doi: 10.1186/s13018-023-04131-7
pii: 10.1186/s13018-023-04131-7
pmc: PMC10466768
doi:
Types de publication
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
639Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Eur J Orthop Surg Traumatol. 2020 Jul;30(5):799-807
pubmed: 31989258
J Orthop Translat. 2020 Apr 23;23:21-28
pubmed: 32455113
Stem Cell Res Ther. 2022 Jul 16;13(1):322
pubmed: 35842714
Acta Histochem. 2022 Aug;124(6):151911
pubmed: 35764040
Stem Cells Transl Med. 2019 Mar;8(3):215-224
pubmed: 30592390
J Immunol Res. 2015;2015:137695
pubmed: 26090476
Int J Nanomedicine. 2021 Dec 16;16:8185-8202
pubmed: 34938076
Ci Ji Yi Xue Za Zhi. 2019 Jan-Mar;31(1):11-19
pubmed: 30692826
Knee. 2021 Dec;33:31-37
pubmed: 34536766
J Orthop Surg Res. 2021 May 31;16(1):352
pubmed: 34059080
J Orthop Surg Res. 2021 Feb 18;16(1):143
pubmed: 33602286
Stem Cell Res Ther. 2019 Nov 21;10(1):340
pubmed: 31753036
Stem Cell Res Ther. 2018 Sep 26;9(1):247
pubmed: 30257711
Cells. 2021 Aug 06;10(8):
pubmed: 34440768
Semin Cell Dev Biol. 2017 Jul;67:56-64
pubmed: 27871993
Biomed Mater Eng. 2017;28(s1):S217-S228
pubmed: 28372298
Medicine (Baltimore). 2022 Sep 16;101(37):e30628
pubmed: 36123928
Annu Rev Physiol. 2015;77:13-27
pubmed: 25293529
Orthop J Sports Med. 2021 Jan 12;9(1):2325967120973052
pubmed: 33490296
Int J Mol Sci. 2021 Mar 05;22(5):
pubmed: 33807695
Osteoarthritis Cartilage. 2017 Apr;25(4):570-580
pubmed: 27789339
Int Orthop. 2021 Feb;45(2):481-488
pubmed: 33068146
Bone Joint Res. 2021 Mar;10(3):226-236
pubmed: 33739851
Mol Med Rep. 2018 Mar;17(3):4474-4482
pubmed: 29328479
Int J Rheum Dis. 2020 Jun;23(6):778-787
pubmed: 32319197
Exp Mol Med. 2018 Sep 21;50(9):1-10
pubmed: 30242147
Stem Cell Rev Rep. 2020 Feb;16(1):126-143
pubmed: 31745710
Stem Cell Res Ther. 2017 Aug 14;8(1):189
pubmed: 28807034
Int J Mol Sci. 2018 Jan 09;19(1):
pubmed: 29315262
Biomaterials. 2013 Jul;34(20):4739-48
pubmed: 23557858
Yeungnam Univ J Med. 2020 Jul;37(3):149-158
pubmed: 32279478
Front Endocrinol (Lausanne). 2022 Jan 14;12:822294
pubmed: 35095776
World J Stem Cells. 2020 Jun 26;12(6):514-526
pubmed: 32742568
Theranostics. 2019 Aug 21;9(22):6587-6600
pubmed: 31588237
Stem Cells Transl Med. 2017 Feb;6(2):613-621
pubmed: 28191757
Cell Death Dis. 2020 Oct 14;11(10):857
pubmed: 33057008
Cell Mol Life Sci. 2022 Oct 20;79(11):557
pubmed: 36264388
J Orthop Surg Res. 2020 Feb 13;15(1):49
pubmed: 32054483
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2016 Dec 8;30(12):1472-1477
pubmed: 29786336
Circ Res. 2017 Oct 27;121(10):1192-1204
pubmed: 28974553
Arch Orthop Trauma Surg. 2020 Apr;140(4):503-509
pubmed: 31980879
Stem Cell Rev Rep. 2020 Jun;16(3):596-611
pubmed: 32112264
Orthop J Sports Med. 2022 Jul 14;10(7):23259671221104409
pubmed: 35859650
J Nanobiotechnology. 2022 Jan 20;20(1):38
pubmed: 35057811
Regen Med. 2022 May;17(5):299-312
pubmed: 35546314
Stem Cells. 2013 Oct;31(10):2136-48
pubmed: 23843355
Cureus. 2020 Sep 21;12(9):e10575
pubmed: 33101819
Biotechnol J. 2017 Dec;12(12):
pubmed: 28902474